Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease

  1. Moreno-Delgado, D.
  2. Puigdellívol, M.
  3. Moreno, E.
  4. Rodríguez-Ruiz, M.
  5. Botta, J.
  6. Gasperini, P.
  7. Chiarlone, A.
  8. Howell, L.A.
  9. Scarselli, M.
  10. Casadó, V.
  11. Cortés, A.
  12. Ferré, S.
  13. Guzmán, M.
  14. Lluís, C.
  15. Alberch, J.
  16. Canela, E.I.
  17. Ginés, S.
  18. McCormick, P.J.
Journal:
eLife

ISSN: 2050-084X

Year of publication: 2020

Volume: 9

Type: Article

DOI: 10.7554/ELIFE.51093 GOOGLE SCHOLAR lock_openOpen access editor